Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.41 |
| ▸ | Q9HBH1 | 1/20 | 0.30 | |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15429788 | 1.00 | TUBB1 (0.41) | TUBB1PDF | |
| SCHEMBL58470 | 1.00 | TUBB1 (0.41) | TUBB1PDF | |
| SCHEMBL16171273 | 0.97 | TUBB1 (0.43) | TUBB1PDF | |
| SCHEMBL14186009 | 0.97 | TUBB1 (0.43) | TUBB1PDF | |
| SCHEMBL15435007 | 0.97 | TUBB1 (0.43) | TUBB1PDF | |
| SCHEMBL13681975 | 0.97 | TUBB1 (0.43) | TUBB1PDF | |
| SCHEMBL16316136 | 0.97 | TUBB1 (0.43) | TUBB1PDF | |
| SCHEMBL12201938 | 0.85 | TUBB1 (0.46) | TUBB1 | |
| SCHEMBL27400344 | 0.81 | TUBB1 (0.51) | TUBB1PDF | |
| SCHEMBL15434849 | 0.81 | TUBB1 (0.50) | TUBB1PDF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140309174-A1 | HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER | EISAI CO., LTD (JP) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140309174-A1 | HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER | DHCR7, HSD17B7, HCCS | TUBB1 1330/4885PDF 1613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.